Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Aliza Ackerstein et al.|Blood|1998Cited by 1.9k
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesShimon Slavin, Reuven Or, Arnon Nagler et al.|Blood|1998Cited by 1.8k
ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)Herman Waldmann, S Slavin, G Hale et al.|The Lancet|1984Cited by 424
T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapseE Naparstek, Shimon Slavin, Reuven Or et al.|British Journal of Haematology|1995Cited by 157